Lisata Therapeutics to Present at NobleCon19 Investor Conference
BASKING RIDGE, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq:LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference, being held December 3-5, 2023 at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL.
Related news for (LSTA)
- Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development
- Lisata Therapeutics to Present at the 2025 BIO International Convention
- Lisata Therapeutics Announces Research License with Catalent
- Lisata Therapeutics to Present at the Investival Showcase USA
- Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development